2[1]Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engle J Med, 1988,319(9) :525-532.
3[2]Fearon ER,Vogestein B. A genetic model for colorectal tumorigenesis. Cell,1990,61(5) :759-767.
4[3]Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 1991,66(3) :589-600.
5[4]Groden J, Gelbert L, Thliveris A, et al. Mutational analysis of patients with adenomatous polyposis:identical inactivating mutations in unrelated individuals. Am J Hum Genet, 1993,52 (2): 263-272.
6[5]Kinzler KW,Vogelstein B. Lessons from hereditary colorectal cancer. Cell,1996,87(2): 159-170.
7[6]Aust DE, Terdiman JP, Wille nbucher RF, et al. The APC/beta-atenin pathway in ulcerative colitis-related colorectal carcinomas:a mutational analysis.Cancer, 2002,94(5): 1421-1427.
8[7]Cooper HS,Everley L,Chang WC,et al. The role of mutant Apc in the development of dysplsaia and cancer in the mouse model of dextran sulfate sodium-induced colitis. Gastroenterology, 2001,121 (6): 1407-1416.
9[8]Mulkens J,Poncin J, Arends JW, et al. APC mutations in human colorectal adenomas:analysis of the mutation cluster region with temperature gradient gel electrophoresis and clinioopathological features. J Pathol, 1998,185 (4):360-365.
10[9]Zhang T,Otevrel T,Gao Z,et al. Evidence that APC regulates survivin expression:a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res,2001,61(24) :8664-8667.
